{"id":4286,"date":"2026-08-26T14:56:00","date_gmt":"2026-08-26T14:56:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/"},"modified":"2026-08-27T03:59:09","modified_gmt":"2026-08-27T03:59:09","slug":"utm_campaignrss-39","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/","title":{"rendered":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-author=\"adam-feuerstein\">\n<p class=\"author-bio\">Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and writer of the e-newsletter Adam\u2019s Biotech Scorecard. You may attain Adam on Sign at stataf.54.<\/p>\n<\/div>\n<div data-author=\"angus-chen\">\n<p class=\"author-bio\">Angus stories on the essential analysis, scientific science, and drug improvement which will remodel survival and high quality of life for sufferers, in addition to developments affecting the most cancers neighborhood. You may attain Angus on Sign at angus.08.<\/p>\n<\/div>\n<div>\n<p class=\"wp-block-paragraph\">The Meals and Drug Administration on Wednesday accepted a life-extending remedy for superior pancreatic most cancers \u2014 a medication made by the biotech firm Revolution Medicines that&#8217;s the first to assault a genetic reason for the aggressive, extremely deadly malignancy.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The drug, referred to as daraxonrasib, might be offered below the model identify Rasonque. The FDA\u2019s approval was supported by a practice-changing scientific trial that learn out earlier this yr. Sufferers with superior pancreatic most cancers who acquired Rasonque as a second-line remedy achieved a median general survival of 13.2 months, in comparison with 6.7 months for sufferers provided normal chemotherapy.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">\u201cWill probably be transformative in the way in which we deal with pancreas most cancers. It\u2019s the most important improvement we\u2019ve had in pancreas most cancers in many years,\u201d stated Andrew Ko, a medical oncologist specializing in gastrointestinal cancers on the College of California, San Francisco. \u201cI\u2019m so grateful for this as an advance for our sufferers.\u201d<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus each day protection and evaluation of the biotech sector \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/08\/26\/pancreatic-cancer-drug-rasonque-approved\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and writer of the e-newsletter Adam\u2019s Biotech Scorecard. You may attain Adam on Sign at stataf.54. Angus stories on the essential analysis, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[2540,303,497,4513,4514,813,4515,496,4512],"class_list":["post-4286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-approves","tag-cancer","tag-drug","tag-expected","tag-extend","tag-fda","tag-lives","tag-pancreatic","tag-rasonque"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24<\/title>\n<meta name=\"description\" content=\"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24\" \/>\n<meta property=\"og:description\" content=\"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T14:56:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-27T03:59:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives\",\"datePublished\":\"2026-08-26T14:56:00+00:00\",\"dateModified\":\"2026-08-27T03:59:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Revmed_campus2-1024x576.jpg\",\"keywords\":[\"approves\",\"cancer\",\"drug\",\"expected\",\"extend\",\"FDA\",\"lives\",\"pancreatic\",\"Rasonque\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/\",\"name\":\"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Revmed_campus2-1024x576.jpg\",\"datePublished\":\"2026-08-26T14:56:00+00:00\",\"dateModified\":\"2026-08-27T03:59:09+00:00\",\"description\":\"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Revmed_campus2-1024x576.jpg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Revmed_campus2-1024x576.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/26\\\/utm_campaignrss-39\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24","description":"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24","og_description":"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/","og_site_name":"Future News 24","article_published_time":"2026-08-26T14:56:00+00:00","article_modified_time":"2026-08-27T03:59:09+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives","datePublished":"2026-08-26T14:56:00+00:00","dateModified":"2026-08-27T03:59:09+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","keywords":["approves","cancer","drug","expected","extend","FDA","lives","pancreatic","Rasonque"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/","name":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","datePublished":"2026-08-26T14:56:00+00:00","dateModified":"2026-08-27T03:59:09+00:00","description":"The drug, made by the biotech company Revolution Medicines, is the first to attack a genetic cause of the aggressive, highly lethal malignancy.\u00a0","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/Revmed_campus2-1024x576.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/26\/utm_campaignrss-39\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"FDA approves Rasonque, pancreatic most cancers drug anticipated to increase lives"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=4286"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4286\/revisions"}],"predecessor-version":[{"id":4287,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/4286\/revisions\/4287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/4288"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=4286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=4286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=4286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}